Dorchester Wealth Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $10.8M | Buy |
75,027
+1,384
| +2% | +$214K | 2.16% | 15 |
|
|
2024
Q3 | $11.9M | Sell |
73,643
-895
| -1% | -$143K | 2.18% | 14 |
|
|
2024
Q2 | $10.9M | Buy |
74,538
+71
| +0.1% | +$10.6K | 2.1% | 13 |
|
|
2024
Q1 | $11.8M | Sell |
74,467
-1,079
| -1% | -$172K | 2.12% | 12 |
|
|
2023
Q4 | $11.8M | Buy |
75,546
+51
| +0.1% | +$7.82K | 2.19% | 10 |
|
|
2023
Q3 | $11.8M | Buy |
75,495
+414
| +0.6% | +$68.3K | 2.38% | 9 |
|
|
2023
Q2 | $12.4M | Buy |
75,081
+1,665
| +2% | +$269K | 2.53% | 6 |
|
|
2023
Q1 | $11.4M | Buy |
73,416
+7,969
| +12% | +$1.29M | 2.34% | 10 |
|
|
2022
Q4 | $11.6M | Sell |
65,447
-5,972
| -8% | -$1.03M | 2.74% | 6 |
|
|
2022
Q3 | $11.7M | Sell |
71,419
-100
| -0.1% | -$16.9K | 2.57% | 8 |
|
|
2022
Q2 | $12.7M | Buy |
71,519
+3,901
| +6% | +$695K | 2.53% | 9 |
|
|
2022
Q1 | $15M | Buy |
67,618
+5,327
| +9% | +$906K | 2.4% | 8 |
|
|
2021
Q4 | $10.7M | Buy |
62,291
+581
| +0.9% | +$95.1K | 2.12% | 12 |
|
|
2021
Q3 | $9.97M | Sell |
61,710
-1,085
| -2% | -$185K | 2.46% | 8 |
|
|
2021
Q2 | $10.3M | Sell |
62,795
-367
| -0.6% | -$60.8K | 2.37% | 11 |
|
|
2021
Q1 | $10.4M | Sell |
63,162
-260
| -0.4% | -$42.1K | 2.58% | 9 |
|
|
2020
Q4 | $9.98M | Sell |
63,422
-1,537
| -2% | -$227K | 2.64% | 8 |
|
|
2020
Q3 | $9.67M | Sell |
64,959
-786
| -1% | -$116K | 2.99% | 8 |
|
|
2020
Q2 | $9.25M | Sell |
65,745
-3,045
| -4% | -$444K | 2.93% | 7 |
|
|
2020
Q1 | $9.02M | Sell |
68,790
-975
| -1% | -$138K | 3.34% | 7 |
|
|
2019
Q4 | $10.2M | Sell |
69,765
-4,687
| -6% | -$636K | 2.83% | 8 |
|
|
2019
Q3 | $9.63M | Sell |
74,452
-795
| -1% | -$105K | 2.83% | 9 |
|
|
2019
Q2 | $10.5M | Sell |
75,247
-2,184
| -3% | -$302K | 3.1% | 6 |
|
|
2019
Q1 | $10.8M | Sell |
77,431
-2,249
| -3% | -$301K | 3.3% | 6 |
|
|
2018
Q4 | $10.3M | Buy |
79,680
+3,681
| +5% | +$513K | 3.58% | 5 |
|
|
2018
Q3 | $10.5M | Buy |
75,999
+4,561
| +6% | +$606K | 3.26% | 6 |
|
|
2018
Q2 | $8.67M | Sell |
71,438
-208
| -0.3% | -$25.9K | 2.85% | 7 |
|
|
2018
Q1 | $9.18M | Buy |
71,646
+4,116
| +6% | +$556K | 3.09% | 6 |
|
|
2017
Q4 | $9.44M | Sell |
67,530
-995
| -1% | -$139K | 2.98% | 7 |
|
|
2017
Q3 | $8.91M | Sell |
68,525
-650
| -0.9% | -$86.2K | 2.86% | 8 |
|
|
2017
Q2 | $9.15M | Sell |
69,175
-532
| -0.8% | -$67.9K | 3.16% | 7 |
|
|
2017
Q1 | $8.68M | Buy |
69,707
+1,007
| +1% | +$120K | 3.02% | 7 |
|
|
2016
Q4 | $7.92M | Sell |
68,700
-355
| -0.5% | -$41K | 2.88% | 8 |
|
|
2016
Q3 | $8.16M | Sell |
69,055
-1,065
| -2% | -$129K | 3.04% | 7 |
|
|
2016
Q2 | $8.51M | Sell |
70,120
-960
| -1% | -$109K | 3.16% | 7 |
|
|
2016
Q1 | $7.69M | Sell |
71,080
-170
| -0.2% | -$17.6K | 2.91% | 7 |
|
|
2015
Q4 | $7.32M | Sell |
71,250
-425
| -0.6% | -$42.7K | 3.04% | 7 |
|
|
2015
Q3 | $8.93M | Buy |
71,675
+880
| +1% | +$85.1K | 3.3% | 6 |
|
|
2015
Q2 | $8.62M | Buy |
+70,795
| New | +$7.09M | 2.84% | 7 |
|
Other funds holding JNJ
Dorchester Wealth Management's JNJ Position: Q4 2024 in Review
Dorchester Wealth Management increased its Johnson & Johnson (JNJ) stake by 1.9% in Q4 2024, buying an estimated $214K and bringing the position to 75,027 shares worth $10.8M. The position accounts for 2.16% of the portfolio, ranked #15.
Dorchester Wealth Management first reported a position in JNJ in Q2 2015 and has held it in 39 quarters since. The position peaked at $15M in Q1 2022. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.
- Dorchester Wealth Management held 75,027 shares of Johnson & Johnson worth $10.8M as of Q4 2024.
- Dorchester Wealth Management bought 1,384 Johnson & Johnson shares in Q4 2024, an estimated $214K.
- Johnson & Johnson made up 2.16% of Dorchester Wealth Management's portfolio in Q4 2024, its #15 holding.
- Dorchester Wealth Management first reported a position in Johnson & Johnson in Q2 2015 and has held it in 39 quarters since.
- Dorchester Wealth Management's Johnson & Johnson position peaked at $15M in Q1 2022.
- 4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.
Based on Dorchester Wealth Management's 13F filing for Q4 2024, filed 4 Feb 2025.